The Treatment of Metastatic Non-small Cell Lung Cancer (NSCLC) in New Era of Personalised Medicine
Lung cancer is the leading cause of cancer related mortality in Canada and USA. Majority of the patients present in advanced stage of the disease and of these only about 2% will be alive at 5 years. NSCLC is the most common form of lung cancer, accounting for approximately 87% of cases. Systemic che...
Saved in:
Main Author: | Barbara Melosky (auth) |
---|---|
Other Authors: | Vera Hirsh (auth) |
Format: | Electronic Book Chapter |
Language: | English |
Published: |
Frontiers Media SA
2015
|
Series: | Frontiers Research Topics
|
Subjects: | |
Online Access: | DOAB: download the publication DOAB: description of the publication |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Update on the Treatment of Metastatic Non-small Cell Lung Cancer (NSCLC) in New Era of Personalised Medicine
by: Barbara Melosky
Published: (2018) -
Second Line Treatment of Non-Small Cell Lung Cancer: Clinical; Pathological and Molecular Aspects of Novel Promising Drugs
by: Umberto Malapelle
Published: (2017) -
Small Cell Lung Cancer: A New Era Is Beginning?
Published: (2021) -
Non-small Cell Lung Cancer: Current Therapies and New Targeted Treatments
Published: (2021) -
Pattern recognition receptors and cancer
by: Anton G. Kutikhin
Published: (2015)